Highlights
NASDAQ: KPTI       Karyopharm Therapeut
Last Price Today's Change   Day's Range   Trading Volume
14.82   -0.78 (5.00%)  14.66 - 15.58  1,095,000

Overview

 
Avg Volume (4 weeks):1,022,615
4 Weeks Range:14.24 - 17.20
4 Weeks Price Volatility (%):
19.59%
52 Weeks Range:13.10 - 29.61
52 Weeks Price Volatility (%):
10.42%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Karyopharm Therapeutics Inc., is a clinical-stage pharmaceutical company focused on the discovery, development and subsequent commercialization of novel, first-in-class drugs directed against nuclear transport and related targets for the treatment of cancer and other major diseases. The company has discovered and is developing small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein, XPO1. Karyopharm’s lead drug candidate, selinexor (KPT-330), is an orally administered agent for the treatment of cancer indications with unmet clinical need, mainly hematologic malignancies. It is also engaged in the clinical development of selinexor in various solid tumor indications.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

3337  5213  557  159 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 BLRX 1.98+0.50 
 AAPL 108.86-6.46 
 NIO 30.58-1.41 
 SQQQ 25.03+1.67 
 SPY 326.54-3.44 
 GE 7.42+0.05 
 TWTR 41.36-11.07 
 F 7.73-0.17 
 CCL 13.71+0.73 
 OAS 0.155-0.014